David Shaw’s Psyence Biomedical Warrant PBMWW Stock Holding History

David Shaw’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.68K	Hold	175,352	–	–	﹤0.01%	4811
2026 Q1	$3.17K	Hold	175,352	–	–	﹤0.01%	4455
2025 Q4	$3.45K	Hold	175,352	–	–	﹤0.01%	4534
2025 Q3	$4.38K	Hold	175,352	–	–	﹤0.01%	4487
2025 Q2	$3.54K	Hold	175,352	–	–	﹤0.01%	4285
2025 Q1	$2.96K	Hold	175,352	–	–	﹤0.01%	4180
2024 Q4	$2.16K	Hold	175,352	–	–	﹤0.01%	4331
2024 Q3	$2.23K	Hold	175,352	–	–	﹤0.01%	4461
2024 Q2	$1.86K	Hold	175,352	–	–	﹤0.01%	4406
2024 Q1	$12.6K	Buy	+175,352	New	+$10.9K	﹤0.01%	4152

Other funds holding PBMWW

HCI

Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

David Shaw's PBMWW Position: Q2 2026 in Review

David Shaw held its Psyence Biomedical Warrant (PBMWW) position steady in Q2 2026 at 175,352 shares worth $3.68K. The position accounts for ﹤0.01% of the portfolio, ranked #4811.

David Shaw first reported a position in PBMWW in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.6K in Q1 2024. 18 funds tracked by Wall St. Rank hold PBMWW as of Q2 2026.

David Shaw held 175,352 shares of Psyence Biomedical Warrant worth $3.68K as of Q2 2026.
David Shaw left its Psyence Biomedical Warrant share count unchanged in Q2 2026.
Psyence Biomedical Warrant made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4811 holding.
David Shaw first reported a position in Psyence Biomedical Warrant in Q1 2024 and has held it in 10 quarters since.
David Shaw's Psyence Biomedical Warrant position peaked at $12.6K in Q1 2024.
18 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.